BlackRock’s Neuraxis NRXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
58,652
+31,298
+114% +$231K ﹤0.01% 4617
2026
Q1
$202K Buy
+27,354
New +$150K ﹤0.01% 4770
2025
Q1
Sell
-2,100
Closed -$4.93K 5494
2024
Q4
$4.93K Buy
+2,100
New +$5.9K ﹤0.01% 5223

Other funds holding NRXS

BlackRock's NRXS Position: Q2 2026 in Review

BlackRock increased its Neuraxis (NRXS) stake by 114% in Q2 2026, buying an estimated $231K and bringing the position to 58,652 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #4617.

BlackRock first reported a position in NRXS in Q4 2024 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • BlackRock held 58,652 shares of Neuraxis worth $429K as of Q2 2026.
  • BlackRock bought 31,298 Neuraxis shares in Q2 2026, an estimated $231K.
  • Neuraxis made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4617 holding.
  • BlackRock first reported a position in Neuraxis in Q4 2024 and has held it in 3 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.